IMPLANTABLE MARKER BODY FOR BREAST TREATMENT
20230038320 · 2023-02-09
Assignee
Inventors
Cpc classification
A61N5/1049
HUMAN NECESSITIES
A61L31/18
HUMAN NECESSITIES
A61B2017/00004
HUMAN NECESSITIES
A61L31/06
HUMAN NECESSITIES
A61B2090/3966
HUMAN NECESSITIES
A61N2005/1061
HUMAN NECESSITIES
A61B90/39
HUMAN NECESSITIES
International classification
A61B90/00
HUMAN NECESSITIES
A61L31/06
HUMAN NECESSITIES
A61L31/18
HUMAN NECESSITIES
Abstract
The invention relates to a marker body (10) for marking breast tissue for radiotherapy. The marker body (10) has an at least partly tube-like body (12) which is made from a soft elastic material and carries multiple radio-opaque marker elements (18). The at least partly tube-like body (12) is designed so that it offers hardly any resistance to an external, deforming force, but returns to its original shape in the absence of external forces. The at least partly tube-like body (12) has two free longitudinal ends (14, 16) which can be detachably interconnected or are interconnected, resulting in a tubular ring.
Claims
1. A marker body for marking breast tissue, the marker body comprising: an at least partially tubular body made from a soft elastic material; and multiple radiopaque marker elements, the radiopaque elements being carried by the tubular body, wherein the at least partially tubular body is configured to provide minimal resistance to an external, deforming force and return to an original shape of the tubular body in the absence of the external, deforming force, and wherein the at least partially tubular body has two free longitudinal ends which are configured to be connected to each other.
2. The marker body as claimed in claim 1, wherein, when the marker body has an external diameter of about 3 cm, the at least partially tubular body is configured to resist an external force with an elastic force of less than about 1 N on about a 1 mm compression path.
3. The marker body as claimed in claim 1, wherein the two free longitudinal ends of the at least partially tubular body are configured to be connected to each other by a plug-in connection.
4. The marker body as claimed in claim 1, wherein at least one of the free longitudinal ends of the at least partially tubular body has a lumen which is configured to receive another free longitudinal end of the at least partially tubular body, or a connecting element, in order to connect the two free longitudinal ends of the at least partially tubular body to each other.
5. The marker body as claimed in claim 1, wherein a connection between the free longitudinal ends of the at least partially tubular body is a clamp connection, in which at least one interconnected free longitudinal end of the at least partially tubular body is at least slightly enlarged compared to an unconnected state of the respective free longitudinal end in order to achieve a clamping action via an elastic restoring force.
6. The marker body as claimed in claim 1, wherein the at least partially tubular body has a continuous lumen, or two or more lumens that, when taken together, extend over more than half of a total length of the at least partially tubular body.
7. The marker body as claimed in claim 1, wherein, in an initial state of the at least partially tubular body, the at least partially tubular body is straight with the unconnected free ends in a relaxed state, and wherein, in a secondary state of the at least partially tubular body, the unconnected free ends are connected to each other such that the at least partially tubular body forms an elastic ring having an approximately circular shape.
8. The marker body as claimed in claim 1, wherein the at least partially tubular body is composed of a soft bioresorbable polymer.
9. The marker body as claimed in claim 8, wherein the polymer is configured such that it is stable for at least 6 months in tissue and is then resorbed.
10. The marker body as claimed in claim 1, wherein the radiopaque marker elements are arranged at a uniform distance from one another on the at least partially tubular body.
11. The marker body as claimed in claim 1, wherein the radiopaque marker elements are configured as metal cylinders and have a length and a diameter of less than about 5 mm and are either inserted into a lumen of the at least partially tubular body or are pressed onto the at least partially tubular body from outside.
12. The marker body as claimed in claim 1, wherein a total length of the at least partially tubular body is between about 7.5 cm and about 30 cm.
13. The marker body as claimed in claim 1, wherein the free longitudinal ends of the at least partially tubular body are configured to be connected by inserting one free longitudinal end into the other free longitudinal end.
14. The marker body as claimed claim 1, wherein the two free longitudinal ends of the at least partially tubular body have the same diameter and are configured to be plugged together via a connecting element.
15. The marker body as claimed in claim 14, wherein the connecting element is composed of a bioresorbable plastic that is harder than a material from which the at least partially tubular body is formed.
16. The marker body as claimed in claim 14, wherein the connecting element is a metal connecting pin that serves as a radiopaque marker element.
17. The marker body as claimed in claim 1, wherein the at least partially tubular body has eyelets or loops such that the marker body may be stitched into a tumor bed to prevent migration of the marker body.
18. The marker body as claimed in claim 1, wherein the marker body is composed of multiple at least partially tubular bodies that are connected to each other at their respective longitudinal free ends.
19. The marker body as claimed in claim 1, wherein the at least partially tubular body has predetermined break points at which the at least partially tubular body can be manually shortened without using a tool.
20. The marker body as claimed in claim 1, wherein the at least partially tubular body has loops at the two free longitudinal ends through which one of the free longitudinal ends may be guided to form a ring that is adjustable in width.
21. The marker body as claimed in claim 1, wherein the marker body is configured to mark a tumor bed for radiotherapy.
22. The marker body as claimed in claim 1, wherein the two free longitudinal ends are configured to be detachably connected to each other.
23. The marker body as claimed in claim 8, wherein the at least partially tubular body is composed of polylactic acid (PLA), of poly-1-lactic acid (PLLA), polyglycolic acid, polycaprolactone, poly-p-dioxanone, ε-caprolactone, and/or Evonik Resomer.
24. The marker body as claim in claim 10, wherein the radiopaque marker elements are arranged at a distance between about 1 cm and about 3 cm from each other.
Description
[0028] The invention will now be explained in further detail based on working examples with respect to the figures. The figures show the following:
[0029]
[0030] possible methods for connecting the intraoperatively free longitudinal ends of the tubular body to each other (
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052] A marker body according to the invention 10 (see
[0053] The tubular body 12 can be configured as a tube with a continuous lumen or can have lumens in sections—in other words, no continuous lumen.
[0054] As shown in particular in
[0055] Preferably, the tubular body 12 is shortened where it has a lumen. The respective lumen 20 of the tubular body 12 serves to connect the longitudinal ends 14, 16 of the tubular bodies 12 with each other. According to a first variant (see
[0056] Alternatively, the lumens 20 at the two longitudinal ends 14 and 16 of the tubular body 12 can also have the same inner diameter. In this case, a separate connecting element 22—for example a connecting pin—can be provided, which can be plugged into the lumens 20 at the two longitudinal ends 14 and 16 of the tubular body 12 in order to allow these longitudinal ends 14 and 16 of the tubular body to be connected to each other; see for example
[0057] Each of the connecting elements 22 can also have at least one marker element 26. Alternatively, the connecting elements themselves may also be configured to be radiopaque so that no separate marker element 26 is required.
[0058] With the connecting elements 22 having more than two connecting ends 24 shown in
[0059] With a connecting element 22 having four connecting ends 24 in conjunction with two tubular bodies 12, a marker body 10″ can be plugged together having for example the shape shown schematically in
[0060] For example, in the marker elements 18 shown in
[0061] The tubular bodies 12 are preferably made from a bioresorbable plastic. The bioresorbable materials listed in the following are suitable: chitosan, chitin and derivatives thereof, PGA (polyglycolide/polyglycolic acid), dextran, PLA (polylactide/polylactic acid), PLLA (poly-L-lactide), PDLA (poly-D/L-lactide), PLDLLA (poly-L-co-D/L-lactide), PLGA (polylactide-co-glycolide), PCL (poly-ε-caprolactone), PEG (polyethylene glycol), PVA (polyvinyl alcohol), PDO (poly-p-dioxanone), PHA (polyhydroxyalkanoate) and PPG (polypropylene glycol).
[0062] Moreover, the following non-resorbable materials are also suitable: silicone, PA (polyamide), PPG (polypropylene glycol), Pebax, polyurethane, PE (polyethylene), LDPE and PVDF (polyvinylidene fluoride).
[0063] The marker elements 18 are preferably composed of a radiopaque metal, such as gold, platinum, nitinol, tantalum, titanium, or plastic with barium sulfate.
[0064] A suitable material for resorbable marker elements 18 is magnesium.
[0065] The marker elements 18 can be clamped onto the outside of the at least partially tubular body. Alternatively, the marker elements 18 can be inserted into corresponding lumens 20 of the tubular body 12 or be cast into the carrier material of the tubular body 12, for example by molding the carrier material around the marker elements, for example in the injection molding process.
[0066] A marker body 10 can also be composed of multiple tubular bodies 12 that are connected to each other at their longitudinal ends. According to a variant, it is provided that the tubular bodies are relatively short, so that do not need to be shortened for adjustment to an implantation site; rather, multiple tubular bodies 12 can be plugged together to form one marker body 10. Examples of this are shown in
[0067] As can also be seen from
[0068] In order to shorten a tubular body 12′ to a desired length even without a tool, the body may have predetermined break points 30, as shown in the example of
[0069] With respect to the marker elements 18,
[0070] In order to allow virtually continuous adaptation of a marker body 10′″ to the respective implantation site, a tubular body 12′″ can also be provided that has a loop 32 (
[0071] Marking elements 18 that are provided in the embodiments according to
[0072]
[0073]
[0074] It can also be seen from
[0092] Further alternative product concepts are explained in the following.
[0093] Product concept: Multiple metal spheres in the tube for ejection into the tumor bed
[0094] Description of the Product Concept:
[0095] The concept comprises multiple marker segments (e.g. 3, 5 or up to 10), a needle (in which the segments are pre-loaded) and an ejector with which the marker segments are individually ejected from the needle.
[0096] Each marker segment is composed of a tube and a marker element that is cast into the tube.
[0097] All of the marker segments are pre-loaded in a needle —one after the other—and can be individually ejected from the needle with an ejector. The needle has an inner diameter I of e.g. 1-3 mm. Each marker segment has a length a of e.g. 2-20 mm, and accordingly, the needle is also several cm long so that all of the marker segments can be housed in said needle.
[0098] The tube is composed of a soft bioresorbable polymer (e.g. PLA, PLLA, polyglycolic acid, polycaprolactone, poly-p-dioxanone, ε-caprolactone, Evonik Resomer, or the like). The polymer should be configured such that it is stable in the tissue for approx. 6 months and is then resorbed, or it can be configured to remain in the tissue permanently. The tube has a smaller diameter than the inner diameter of the needle. The tube can be made of a material that increases its volume on contact with water (e.g. a hydrogel). The tube can also be coated in order to ensure biocompatibility, for example. Or the tube can be coated in order to ensure that it is pushed out of the cannula.
[0099] Inside the tube, e.g. in the middle of each segment, is a marker element. The marker elements are characterized by being visible on x-rays and CT images. Biocompatible metals such as gold, titanium or Nitinol are conceivable for this purpose. Materials such as magnesium, carbon and calcium, which absorb x-ray radiation, are also conceivable.
[0100] The marker elements can for example take on the shape of small spheres (outer diameter b 0.5-3 mm) or cylinders (outer diameter 0.5-3 mm, length 0.5-3 mm). Other geometric shapes, such as cubes, tetragons, hexagons, and octagons are also conceivable.
[0101] During application, a segment is pushed out of the needle at particular site and placed. After this, the needle can be guided to another site, and a further segment can be placed there. Thus a single needle can be used to distribute the segments throughout the entire tumor bed.
[0102] Drawing of the Product Concept:
[0103]
[0104] Product concept: Flexible mesh
[0105] Description of the Product Concept:
[0106] The flexible mesh can be adapted to the shape of the wound cavity and is fastened to the margins of the wound cavity using resorbable suture material or tissue adhesives (such as fibrin adhesives). This ensures that the mesh does not migrate and the margins of the tumor beds are permanently identifiable.
[0107] The mesh should not be palpable in the breast postoperatively. It is composed of a polymer or copolymer (for example glycolide and trimethylene carbonate, polyglycolic acid-caprolactone). The polymer should be configured such that it is stable in the tissue for approx. 6 months and is then resorbed. A non-resorbable mesh would also be conceivable (i.e. of polypropylene, polyester or polyamide). If non-resorbable material is used, flexibility must be constructively achieved in order to obtain the desired non-palpability. The mesh is available in different sizes (depending on the size of the tumor bed, margin length a=5, 10, 15, 20 and 25 cm) or can be cut to the desired size, so that it is individually adaptable to various tumor beds and different sizes. The distance b between the meshes is 0.5 to 4.0 mm. The flat shape allows adaptation to common oncoplastic surgical techniques.
[0108] One possibility would be for the mesh per se to be radiopaque (addition of a radiopaque material such as BaSO.sub.4, tantalum, gold, titanium) and thus clearly visible on CT. Based on CT images, exact irradiation of the tumor bed can be planned, thus protecting the surrounding health tissue from irradiation. Another possibility would be to equip the visible mesh with radiopaque markers (markers of titanium, platinum, tantalum, gold at intervals b of approx. 0.5-4.0 mm, or up to a multiple of these values by omitting several nodes) and to use the multiple point markers as a reference for the irradiation planning. Because the mesh can be adapted to the shape of the tumor beds, this makes 3D orientation possible in irradiation planning.
[0109]
[0110] Product concept: 3D matrix/compressible ball
[0111] Description of the Product Concept:
[0112] The compressible and postoperatively non-palpable 3D matrix/compressible and postoperatively non-palpable ball (referred to in the following as the marker) constitutes a (porous) resorbable scaffolding and is composed of a polymer (e.g. polydioxanone, collagens or polyethylene glycol), which after implantation is to allow regeneration of the natural breast tissue. The polymer is to be configured such that it is stable for approx. 6 months in the tissue and is then resorbed. In addition, the resorption rate is matched to the growing tissue. If non-resorbable material (such as silicone) is used, flexibility must be constructively achieved in order to obtain the desired non-palpability. The marker could be produced by a 3D printing method.
[0113] The marker is available in different sizes (depending on the size of the tumor bed, margin length/diameter a=1, 2, 3, 4 and 5 cm) or can be cut/torn to the desired size in the OP (at predetermined break points). In order to prevent the marker from migrating, it is fastened to the margin of the tumor bed.
[0114] One possibility would be for the marker per se to be radiopaque (addition of a radiopaque material such as BaSO.sub.4, tantalum, gold, titanium) and thus clearly visible on CT. Another possibility would be to equip the marker with radiopaque markers arranged at certain intervals inside and on the edge of the matrix/ball (markers of platinum, tantalum, gold at intervals of approx. 0.51 cm). The multipoint markers thus provide a 3D orientation in space and serve as a reference for the irradiation planning. Based on CT images, exact irradiation of the tumor bed can be planned, thus protecting the surrounding healthy tissue from irradiation.
[0115] The marker also fills the three-dimensional shape of the tumor cavity, thus preventing the breast from collapsing at this site. The tissue can grow into the marker. In addition to accurate irradiation planning, the marker would support the cosmetic aspect of reconstruction.
[0116]
[0117] Product concept: Resorbable magnesium spheres (as x-ray markers) connected to a resorbable thread/wire
[0118] Description of the Product Concept:
[0119] The resorbable magnesium spheres (as x-ray markers) (the spheres need not be composed of pure magnesium, but can also be composed of a magnesium alloy, such as e.g. magnesium and neodymium as an additive, which makes it stronger and highly moldable) are connected to one another with a resorbable thread/wire (for example of magnesium/magnesium alloy or polylactic acid). The thread/wire is plastically deformable and thus adaptable to the wound cavity. The thread/wire can be cut to the desired size/length (total length I of the thread/wire=30-50 cm, interval a of the x-ray markers=1-3 cm). A needle is attached to the front end of the thread/wire so that the thread/wire, including the magnesium spheres, can be directly stitched into the wound cavity. This gives rise to a three-dimensional construct, which allows the wound cavity to be reliably localized and based on which the irradiation planning can be carried out.
[0120] The resorption time of the magnesium spheres can be controlled by means of various coatings. The coating is to be configured such that the magnesium spheres are stable for approx. 6 months in the tissue and are then resorbed. As a variant, if magnesium is not sufficiently radiopaque, materials such as tantalum or gold can also be used as x-ray markers.
[0121] Drawing of the Product Concept:
[0122]
[0123] Product Concept:
[0124] Radiotherapy Thread with Metal Segments
[0125] Description of the Product Concept:
[0126] The product concept has the shape of a thread into which a plurality of marker elements is incorporated. The thread is made of a material used for surgical thread. The thread is composed of a material that is resorbed after a period of time (e.g. PLA, i.e. polylactic acid). The thread is (plastically) deformable and thus adaptable to the wound cavity. The thread can have a length I of for example 30-100 cm. The diameter of the thread roughly corresponds to the diameter of the other suture material.
[0127] The marker elements are characterized by being visible on x-ray and CT images. The marker elements are also characterized in that they are similar to the thread in flexibility, and in the ideal case, even have the same diameter. Conceivable for this purpose are threads, strands or thin wires of biocompatible metals such as e.g. gold, titanium or metal alloys such as e.g. Nitinol.
[0128] Each marker element can for example have a length b of 5-20 mm. For example, 5-50 such elements can be distributed along the entire length of the thread. The marker elements can be uniformly distributed along the thread, or rather unevenly distributed.
[0129] In order to be able to produce the radiotherapy threads, for example, the marker elements are connected to thread segments by adhesive bonding, welding, lasers, etc. The marker elements can also be cast or pressed into the thread.
[0130] A needle is attached to the front end so that the radiotherapy threads, including the Nitinol segments, can be directly stitched into the wound cavity. This gives rise to a three-dimensional construct, which allows the wound cavity to be reliably localized and based on which the irradiation planning can be carried out.
[0131] Drawing of the product concept:
[0132] Product concept: Silicone marker/hydrogel marker
[0133] Description of the Product Concept:
[0134] a.) Silicone as a basic material:
[0135] (available as silicone foam as an implant material, but can also be produced by injection-molding-like methods)
[0136] Shapes: (depending on tumor bed size in diameter a=1, 2, 3, 4 and 5 cm) [0137] 2D or 3D star or [0138] Spiral (similar to the spiral of the Somatex lung marker/BioZorb) or [0139] Spiral band/string (if same profile is consistently selected, the implant could optionally be removed by means of minor surgical intervention)
[0140] Radiopaque by: [0141] small metal parts, optionally tantalum, gold, etc. or [0142] addition of BaSO.sub.4 or other admixtures to the silicone base composition prior to polymerization
[0143] Implementation Idea:
[0144] For example, a 3D silicone star composed of four prongs oriented in such a way that the distance between each of the four tips is the same (this could possibly make the radiotherapy planning simpler). Radiopaque markers are attached to the tips, which serve as a reference for the irradiation planning and allow 3D orientation. The silicone ensures that the star is not palpable in the breast postoperatively. In addition, the marker is available in different sizes (depending on the size of the tumor bed). In order to prevent migration of the marker, the star is attached (at its tips) to the margin of the tumor bed.
[0145] b.) Hydrogel as a Basic Material:
[0146] (only as a slowly resorbable variant with a low quelling factor, optionally based on PMMA or cytosan)
[0147] Shapes: (depending on tumor bed size in diameter a=1, 2, 3, 4 and 5 cm) [0148] 2D or 3D star of [0149] Spiral (similar to the spiral of the Somatex lung marker/BioZorb) or [0150] Spiral band/string
[0151] Radiopaque by: [0152] small metal parts, optionally tantalum, gold, etc. or [0153] addition of BaSO.sub.4 or other admixtures
[0154] Implementation Concept:
[0155] See example of silicon esters, only with hydrogel
[0156] Drawing of the Product Concept:
[0157]